RETRACTED: Alhakamy et al. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021, 13, 977
- PMID: 38276523
- PMCID: PMC10819119
- DOI: 10.3390/pharmaceutics16010150
RETRACTED: Alhakamy et al. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021, 13, 977
Abstract
The journal retracts the article, "Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans" [...].
Retraction of
-
Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans.Pharmaceutics. 2021 Jun 28;13(7):977. doi: 10.3390/pharmaceutics13070977. Pharmaceutics. 2021. Retraction in: Pharmaceutics. 2024 Jan 22;16(1):150. doi: 10.3390/pharmaceutics16010150. PMID: 34203359 Free PMC article. Retracted.
References
-
- Alhakamy N.A., Al-Rabia M.W., Md S., Sirwi A., Khayat S.S., AlOtaibi S.S., Hakami R.A., Al Sadoun H., Eldakhakhny B.M., Abdulaal W.H., et al. RETRACTED: Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics. 2021;13:977. doi: 10.3390/pharmaceutics13070977. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
